US20080261285A1 - Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch - Google Patents
Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch Download PDFInfo
- Publication number
- US20080261285A1 US20080261285A1 US12/155,180 US15518008A US2008261285A1 US 20080261285 A1 US20080261285 A1 US 20080261285A1 US 15518008 A US15518008 A US 15518008A US 2008261285 A1 US2008261285 A1 US 2008261285A1
- Authority
- US
- United States
- Prior art keywords
- starch
- lactic acid
- fermentation
- glucoamylase
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 132
- 229920002472 Starch Polymers 0.000 title claims abstract description 78
- 235000019698 starch Nutrition 0.000 title claims abstract description 75
- 239000008107 starch Substances 0.000 title claims abstract description 75
- 238000000855 fermentation Methods 0.000 title claims abstract description 74
- 230000004151 fermentation Effects 0.000 title claims abstract description 74
- 239000004310 lactic acid Substances 0.000 title claims abstract description 65
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 65
- 238000000034 method Methods 0.000 title claims abstract description 63
- 150000003839 salts Chemical class 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title abstract description 15
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims abstract description 40
- 102100022624 Glucoamylase Human genes 0.000 claims abstract description 39
- 244000005700 microbiome Species 0.000 claims abstract description 36
- 108090000637 alpha-Amylases Proteins 0.000 claims description 42
- 102000004139 alpha-Amylases Human genes 0.000 claims description 22
- 229940024171 alpha-amylase Drugs 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 16
- 241000193749 Bacillus coagulans Species 0.000 claims description 15
- 229940054340 bacillus coagulans Drugs 0.000 claims description 15
- 241000193399 Bacillus smithii Species 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 235000000346 sugar Nutrition 0.000 description 15
- 229920002774 Maltodextrin Polymers 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 241001495667 Bacillus thermoamylovorans Species 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 8
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 8
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 239000002002 slurry Substances 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 150000008163 sugars Chemical class 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 3
- 239000000920 calcium hydroxide Substances 0.000 description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001592 potato starch Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000626621 Geobacillus Species 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 108050008938 Glucoamylases Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 2
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- QIGJYVCQYDKYDW-NSYYTRPSSA-N nigerose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-NSYYTRPSSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-M (S)-lactate Chemical compound C[C@H](O)C([O-])=O JVTAAEKCZFNVCJ-REOHCLBHSA-M 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 102100033770 Alpha-amylase 1C Human genes 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000209134 Arundinaria Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229920002245 Dextrose equivalent Polymers 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101000779870 Homo sapiens Alpha-amylase 1B Proteins 0.000 description 1
- 101000779869 Homo sapiens Alpha-amylase 1C Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 241000186714 Lactobacillus amylophilus Species 0.000 description 1
- 241000186713 Lactobacillus amylovorus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 241000204117 Sporolactobacillus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 235000009430 Thespesia populnea Nutrition 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- -1 alkali metal salts Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Definitions
- the present invention pertains to a method for the production of lactic acid or a salt thereof wherein starch is subjected to a process of simultaneous saccharification and fermentation.
- Fermentation processes are exploited for the manufacture of a vast number of products of considerable commercial interest and which are difficult to produce synthetically. Fermentation is used in industry to produce simple compounds among which alcohols, such as ethanol and butanol; organic acids, such as citric acid, itaconic acid, (R)- or (S)-lactic acid and gluconic acid; ketones; amino acids, such as glutamic acid and lysine; but also more complex compounds as antibiotics, such as penicillin and tetracyclin; enzymes; vitamins, such as riboflavin, vitamin B 12 and bet ⁇ -carotene; and hormones. Also in the brewing, wine, dairy, leather and tobacco industry fermentation processes are used.
- liquefied starch means starch that has been subjected to the process of liquefaction, which means acid, enzymic, or thermomechanical fluidification of starch leading to a dissolved or soluble form.
- malto-oligosaccharides means maltosaccharides composed of ⁇ -1,4-glucosidic linkages of anhydroglucose units having a degree of polymerization (DP n ) of 2-50 (n) such as maltose, maltotriose, maltotetraose, or maltopentaose and the like.
- degree of polymerization or DP n means the number of anhydroglucopyranose units in a given saccharide.
- Maltose having two ⁇ -1,4-glucosidic linked glucose residues may be referred to as DP 2 ; maltotriose, having three ⁇ -1,4-glucosidic linked glucose residues may be referred to as DP 3 and so on.
- maltodextrin means a starch hydrolysis product having a DE of less than 20.
- DE dexrose equivalent
- DE reducing power (loss of electrons due to presence of carbonyl function) expressed as D-glucose on a dry basis.
- dry basis means the composition based on the absence of water. For instance, a product containing 25 wt. % of component A, 25 wt.
- lactic acid means 2-hydroxypropionic acid in either its free acid or salt form.
- the salt form of lactate is specifically referred to as lactate-salt, e.g. as either the calcium salt of lactic acid or calcium lactate.
- Alkali and earth alkali metal salts of lactic acid are preferred.
- Lactic acid contains a chiral carbon atom, and for that reason can exist as (R) and (S) enantiomer.
- lactic acid as used in this application includes the pure (R) and (S) isomers, and mixtures thereof including the racemic mixture.
- enantiomeric purity for an excess (S)-isomer means
- saccharification means the acid- or enzymic-hydrolysis of starch or liquefied starch or maltodextrines or maltooligosaccharides that ultimately results in the production of D-glucose or maltose or small maltooligosaccharides or mixtures thereof.
- ⁇ -amylase means an enzyme belonging to the functional-class with the EC number 3.2.1.1 and the trivial name glycogenase, diastase, fungal ⁇ -amylase, or bacterial ⁇ -amylase, and the systematic name 1,4- ⁇ -D-glucan glucanohydrolase.
- ⁇ -Amylases partially depolymerize polysaccharides containing three or more 1,4- ⁇ -linked D-glucose units by endohydrolysis of 1,4- ⁇ -D-glucosidic linkages.
- glucoamylase means an enzyme belonging to the functional-class with the EC number 3.2.1.3 and the trivial name glucoamylase, ⁇ -amylase, lysosomal ⁇ -glucosidase, acid maltase, exo-1,4- ⁇ -glucosidase, glucozyrne, AMG, or GAM, and the systematic name 1,4- ⁇ -D-glucan glucohydrolase.
- Glucoamylases hydrolyze terminal 1,4-linked ⁇ -D-glucose residues successively from the non-reducing ends of the chains with release of ⁇ -D-glucose, and they hydrolyze the ⁇ -1,6 linkages.
- pullulanase means an enzyme belonging to the functional-class with the EC number 3.2.1.41 and the trivial name limit-dextrinase, debranching enzyme, or amylopectin 6-glucanohydrolase, and the systematic name ⁇ -dextrin-6-glucanohydrolase or pullulan 6-glucanohydrolase. Pullulanases debranched starch by hydrolysing the ⁇ -1,6 linkages.
- starch means any purified or crude starch or liquefied starch, or any starch-or liquefied starch-containing material. Wheat, corn, rye, and potato starch are examples of starches that can usefully be applied in the present invention.
- SSF saccharification and fermentation
- Fermentation of starch or liquefied starch to lactic acid is known in the art, for example from EP 354828 A1, wherein a process for producing lactic acid is disclosed, which includes incubating Lactobacillus delbrueckii subsp lactis or Lactobacillus rhamnosus in fermentation broth containing liquefied wheat starch and a preparation of a glucoamylase to produce a lactate-containing fermentation broth.
- Hofvendahl et al in Appl. Biochem. Biotechnol., 52: 163-169 (1999) describe an SSF-system with Lactococcus lactis in fermentation broth-containing wheat starch. Linko et al in Enz. Microb.
- Biotechnol., 70/72: 417-428 describe an SSF-system with a Lactobacillus species in fermentation broth-containing potato starch.
- the term “fermentation broth” refers to both media in the form originally provided to microorganisms as a source of nutrients, growth factors and carbohydrates and media produced after some or all of the originally provided nutrients, growth factors, or carbohydrates have been consumed and fermentation products including lactic acid have been excreted into the media by the microorganisms.
- microorganisms such as Lactobacillus species, Lactococcus species, Streptococcus species, Enterococcus species, and Sporolactobacillus species are producers of lactic acid, certain properties make these organisms less suitable for the industrial manufacture of lactic acid, including the fact that they have a growth temperature in the range of 30-50° C., with an optimum at 30-37° C., which makes it more difficult to avoid infections in industrial scale fermentation systems, which compromise the enantiomeric purity of the lactic acid during the fermentation than when higher temperatures can be used.
- the growth-temperature range of these microorganisms is not congruent with the application temperature range of glucoamylase and pullulanase, which is in the range of 50-70° C. and of ⁇ -amylase, which is in the range 80-105° C.
- a lactic fermentation with the microorganisms operated as SSF at a temperature which is optimal for these microorganism is sub-optimal for the activity of the enzyme.
- thermophilic nutritionally less demanding lactic acid-producing bacteria are more favorable.
- the invention therefore pertains to a method for the production of lactic acid or a salt thereof wherein starch is subjected to a process of simultaneous saccharification and fermentation, the method comprising saccharifying starch in a medium comprising at least a glucoamylase and simultaneously fermenting the starch using a microorganism, and optionally isolating lactic acid from the medium, characterized in that a moderately thermophilic lactic acid-producing microorganism is used.
- moderately thermophilic Bacillus species for the manufacture of lactic acid from simple sugars such as glucose and sucrose is known in the art.
- the term “moderately thermophilic” means bacterial strains, which are capable of growing at temperatures between 30-65° C., with an optimum between 40-60° C., more preferably between 50-60° C.
- U.S. Pat. No. 5,002,881 and DE 4000942 disclose processes to produce lactic acid which include incubating strains of Bacillus coagulans at 48-54° C. in a simple fermentation medium containing either glucose or sucrose as carbohydrate to produce a lactate containing fermentation broth.
- enantiomerically pure lactic acid or a salt thereof can now easily be prepared.
- enantiomerically pure means that the enantiomeric purity is at least 95%, preferably at least 98%, and more preferably at least 99%.
- Bacillus coagulans and Bacillus thermoamylovorans are excellent lactate producers, they also have certain properties which at first sight would render these organisms less suitable candidates for the manufacture of enantiomerically pure lactic acid from starch or liquefied starch.
- Bacillus thermoamylovorans is heterolactic, which means that a fraction of the carbohydrate substrate is fermented to products other than lactic acid (ethanol, acetic acid, and formic acid), thereby lowering the product yield (mol lactic acid per mol carbohydrate) and rendering the product lactic acid more difficult to purify.
- Bacillus coagulans and Bacillus thermoamylovorans have a relatively high pH optimum (6.0-7.0) for lactic acid production, which is substantially higher in pH units than the preferred application (working) pH range of glucoamylase (3.5-5).
- the application pH range of glucoamylase is thus not congruent with that of the microorganism.
- a lactic fermentation with the moderately thermophilic Bacillus coagulans and Bacillus thermoamylovorans operated as SSF at a pH that is optimal for the microorganism reduces the activity of the glucoamylase. This can be compensated by adding more glucoamylase, but this will add to the costs.
- This strain has a high rate of substrate conversion and high production yield. It is known, that at high free glucose concentrations glucoamylase can give a reversed reaction to produce ⁇ -1,4, ⁇ -1,6 and ⁇ -1,3 linkages from glucose producing sugars, such as maltose, isomaltose and nigerose, which are poorly or not fermentable by moderately thermophilic lactic acid bacteria (e.g.
- the starch is saccharified, fermented, and optionally liquefied in a mixture of glucoamylase and at least one of pullulanase and ⁇ -amylase.
- the instant process results in that substantially less residual sugars are obtained compared with conventional fermentation processes, making direct isolation of lactic acid possible.
- the present invention thus provides in an advantage of an easy and inexpensive work-up procedure, not longer necessitating a complex extraction step to separate the lactic acid from residual sugars.
- An additional advantage of the instant process is the possibility of using crude starch, since the low residual sugar amounts not longer require the use of purified starch as starting product. Usually residual sugar contents less than 5 g/l, preferably less than 2 g/l are easily obtainable with the process of the invention.
- saccharification is performed by glucoamylase or a mixture of glucoamylase and ⁇ -amylase and/or pullulanase.
- Glucoamylase EC 3.2.1.3, 1,4- ⁇ -D-glucan glucohydrolase
- Glucoamylase is an exohydrolase and attacks di-, oligo- and polysaccharides-containing glucose predominantly bound together by ⁇ -1,4-glucosidic linkages, though ⁇ -1,6-glucosidic linkages and ⁇ -1,3-glucosidic linkages are attacked at lower rates.
- This is of considerable industrial interest, as starch-hydrolysates after ⁇ -amylase treatment contain ⁇ -1,6-glucosidic linkages that must be cleaved if acceptable glucose yields are to be obtained. Since the activity of glucoamylase towards ⁇ -1,6-glucosidic linkages is low, some commercially available glucoamylase preparations contain pullulanase.
- Pullulanase is a so-called debranching enzyme, which cleaves the ⁇ -1,6-glucosidic linkages present in starch and liquefied starch.
- enzyme-containing glucoamylase as main component as well as combination preparations containing glucoamylase and pullulanase appeared suitable for the process according to the present invention.
- the application pH range for glucoamylase and pullulanase was found to be optimal between 3.5 and 5.
- the application temperature range was found optimal between 55-70° C.
- the effect of calcium lactate and pH on the activity and stability of the enzyme was found not to become progressively worse as a result of the accumulation of fermentation product.
- glucoamylase/pullulanase preparations (ex Genencor and Novo Nordisk) were tested. All contained a considerable debranching activity.
- AMGTM E (ex Novo Nordisk), a glucoamylase with a high debranching activity, DextrozymeTM E (containing glucoamylase and pullulanase) (ex NOVO Nordisk), and OptimaxTM 7525 HP (containing glucoamylase and pullulanase) (ex Genencor) were also tested and again no large difference was observed between these preparations. DextrozymeTM E performed slightly less than AMGTM E and OptimaxTM 7525 HP regarding overall fermentation performance. AMGTM E and OptimaxTM 7525 HP performed almost identical and both enzyme preparations were studied in detail (see Experimental).
- the fermentation is performed by a moderately thermophilic lactic acid producing microorganism such as microorganisms derived from a strain of Bacillus coagulans, Bacillus thermoamylovorans, Bacillus smithii, Geobacillus stearothermophilus , or from mixtures thereof. These microorganisms are capable of growing at temperatures between 30-65° C. Thus these microorganism are better adjusted to work in the optimal working temperatures of the enzymes and the process according to the invention is usually conducted at a temperature between 30-70° C.
- the method of the invention is usually performed at pH 3-8.5, preferably at pH 5-6, more preferably at pH 5.35-5.80, most preferably at pH 5.50-5.60.
- thermophilic lactic acid-producing microorganism it is an advantage to adapt the thermophilic lactic acid-producing microorganism to the pH range as used in the process.
- the pH strongly influences the activity.
- the enzymes become progressively more active at low pH values.
- the common pH ranges in which moderately thermophilic lactic acid-producing microorganism perform optimal is between 6.0 and 7. Therefore, it is preferred to use moderately thermophilic lactic acid-producing microorganism, which has been adapted to have its maximum performance at low pH (between 5 and 6, preferably between 5.35-5.80, most preferably between 5.35-5.80).
- the technique of adapting the microorganism is known in the art. Adaptation or acclimation of moderately thermophilic lactic acid-producing bacteria to improve the performance at pH 5.35-5.8 was accomplished by carrying out 40-50 serial transfers in fermentation medium at pH 5.6.
- the simultaneous saccharification and fermentation may be performed on a starch slurry or on any other starch-containing composition.
- Said starch may be liquefied or not. If a non-liquefied starch slurry or any other starch containing composition is used, the saccharification and fermentation may be combined with liquefaction and also an ⁇ -amylase may be present in the fermentation medium.
- a full saccharification step may last up to 72 hours. However, it is possible to do a pre-saccharification of typically 40-90 minutes and then complete saccharification during fermentation. Said pre-saccharification step may be conducted at a temperature above 50° C., just prior to the fermentation.
- the most widely used process is a simultaneous saccharification and fermentation (SSF) process where there is no holding stage for the saccharification, meaning that fermenting organism and enzyme(s) is (are) added together.
- SSF simultaneous saccharification and fermentation
- the moderately thermophilic lactic acid producing microorganism and enzyme(s) may also be added simultaneously.
- the process according to the invention may also be performed by a pre-saccharification followed by a simultaneous saccharification and fermentation wherein an additional portion of the enzymes is added with the addition of the moderately thermophilic lactic acid-producing microorganism.
- a starch slurry or slurry of a suitable starch-containing material or liquefied starch is fed into a fermenter.
- the microbial inoculum and nutrients are also fed into the fermenter.
- a suitable base such as calcium hydroxide, sodium hydroxide, potassium hydroxide, magnesium hydroxide, magnesium oxide, ammonia, ammonium hydroxide or a suitable carbonate such as calcium carbonate, sodium carbonate, sodium hydrogencarbonate, potassium carbonate, potassium hydrogencarbonate, magnesium carbonate, ammonium carbonate may be added for pH control.
- gelatinized starch or starch containing material When applied, in the liquefaction step of the invention, gelatinized starch or starch containing material is broken down (hydrolyzed) to maltodextrines with an average DE between 10 and 30.
- gelatinization means the process that transforms starch granules into starch paste.
- the hydrolysis may be carried out by acid treatment or enzymatically by ⁇ -amylase treatment.
- the ⁇ -amylase derived from a microorganism or a plant.
- Preferred ⁇ -amylases are of fungal or bacterial origin. A definition of ⁇ -amylase is given above.
- the enzymatic liquefaction process may be carried out at a pH between 5 and 6, preferably between 5.35 and 5.80, and more preferably between 5.50 and 5.60.
- enzymatic liquefaction may advantageously be combined with either the pre-saccharification or the simultaneous saccharification and fermentation or with both.
- Acid hydrolysis although its use is not wide spread, may also be used.
- the raw material may be milled (whole) cereals or rasped, shredded roots (potato, tapioca), tubers, whole grains, corns, cobs, wheat, barley, rye, milo, sugar-containing raw materials, such as molasses, fruit materials, sugar, cane or sugar beet, potatoes, cellulose-containing materials, such as wood or plant residues.
- a side stream from starch processing such as co-called B-starch may also be used.
- Liquefaction is known in the art and needs no further elucidation here. As indicated-above, the liquefaction may also take place in combination with the saccharification and fermentation.
- the hot slurry is heated to between 60-95° C., preferably 80-85° C., and at least an ⁇ -amylase is added;
- the slurry is jet-cooked at a temperature between 95-140° C., preferably 105-125° C. to complete gelanitization of the slurry;
- the liquefaction process may be carried out at pH 5-6, in particular at a pH between 5.35 and 5.80, most preferably at pH 5.50-5.60.
- lactic acid After combined saccharification and fermentation the formed lactic acid is optionally isolated from the fermentation medium and purified when necessary.
- Conventional purification/isolation methods for lactic acid are distillation, extraction, electrodialysis, adsorption, ion-exchange, crystallization and the like, and combinations of the above-mentioned purification/isolation methods. Distillation is the most commonly used technique. However, as explained above, with the process according to the invention the formation of non-fermentable sugars is reduced. Therefore, isolation or purification steps may be less complicated and sometimes even redundant. Further details on how to carry out distillation, and other techniques for recovering of lactic acid are well known to the skilled person. The invention is further illustrated by the following experiments, which are included without restricting the invention thereto.
- the culture Bacillus coagulans that was adapted to pH 5.65 was cultivated in a 3-liter glass jacketed stirred reactor equipped with temperature and pH control (Applikon, Schiedam, The Netherlands). The culture was routinely maintained, by transferring every 24 hours 180-200 ml of an actively fermenting culture to a fermenter containing a freshly prepared batch of maltodextrine-medium (see Table 1). Fermentations were performed with pure maltodextrines as well as liquefied starch from the Cargill Refinery in Blair (Nebraska, USA) and glucose syrup also from the Cargill Refinery in Blair (Nebraska, USA)(see Table 1).
- the temperature of the fermenters was controlled at 54-56° C. by means of a circulating water bath.
- the pH set point was a compromise between the optimum pH of the enzyme and the optimum for Bacillus coagulans that was adapted to pH 5.65.
- the fermentation was started at pH 6.0 and as a result of the formation of lactic acid allowed to drop. Upon reaching pH 5.55-5.75 the pH was controlled by the automatic addition of calcium hydroxide (250 g/l). After 24 hours fermentation the culture received a second portion of AMG ETM (Novozymes). The fermentation was allowed to proceed until the demand for calcium hydroxide ceased. This was the case after 30-40 hours incubation.
- the benchmark for the SSF fermentation was set by the fermentation with glucose syrup (DE 98) as substrate.
- the SSF study was started with a maltodextrine preparation from Roquette Freres (GlucidexTM 12, DE 11-14) and successfully finished.
- Two glucoamylase preparations were extensively tested: AMG ETM from Novozymes (glucoamylase with high debranching activity) and OptimaxTM 7525 HP from Genencor (glucoamylase/pullulanase).
- a typical SSF fermentation on pure maltodextrines was free of residual sugars within 2 days. The main residual sugars present were glucose and isomaltose, however, at a consistently lower concentration than in comparable cultures that received DE 98 glucose syrup as substrate.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention pertains to a method for the production of lactic acid or a salt thereof wherein starch is subjected to a process of simultaneous saccharification and fermentation, the method comprising saccharifying starch in a medium comprising at least a glucoamylase and simultaneously fermenting the starch using a microorganism, and optionally isolating lactic acid from the medium, characterized in that a moderately thermophilic lactic acid-producing microorganism is used. The invention further relates to a method of performing said process in the presence of a moderately thermophilic lactic acid producing microorganism, which has been adapted to have its maximum performance at the working pH.
Description
- This is a Divisional of application Ser. No. 10/514,161 filed Dec. 21, 2004, which in turn is a National Stage of PCT/EP03/50159, filed May 13, 2003. The disclosures of the prior applications are hereby incorporated by reference herein in their entirety.
- The present invention pertains to a method for the production of lactic acid or a salt thereof wherein starch is subjected to a process of simultaneous saccharification and fermentation.
- Fermentation processes are exploited for the manufacture of a vast number of products of considerable commercial interest and which are difficult to produce synthetically. Fermentation is used in industry to produce simple compounds among which alcohols, such as ethanol and butanol; organic acids, such as citric acid, itaconic acid, (R)- or (S)-lactic acid and gluconic acid; ketones; amino acids, such as glutamic acid and lysine; but also more complex compounds as antibiotics, such as penicillin and tetracyclin; enzymes; vitamins, such as riboflavin, vitamin B 12 and betα-carotene; and hormones. Also in the brewing, wine, dairy, leather and tobacco industry fermentation processes are used.
- Sugar is the most important contributor to the manufacturing cost price of lactic acid. Major reductions in the manufacturing cost price of lactic acid can therefore be accomplished if the manufacturing process is fed with cheap sugar. Starch and partial hydrolysates of starch, the latter also known as liquefied starch, which can also be purified to products such as maltooligosaccharides or maltodextrines, represent such cheap sources. The term “liquefied starch” means starch that has been subjected to the process of liquefaction, which means acid, enzymic, or thermomechanical fluidification of starch leading to a dissolved or soluble form. The term “malto-oligosaccharides” means maltosaccharides composed of α-1,4-glucosidic linkages of anhydroglucose units having a degree of polymerization (DPn) of 2-50 (n) such as maltose, maltotriose, maltotetraose, or maltopentaose and the like. The term “degree of polymerization” or DPn means the number of anhydroglucopyranose units in a given saccharide. Maltose, having two α-1,4-glucosidic linked glucose residues may be referred to as DP2; maltotriose, having three α-1,4-glucosidic linked glucose residues may be referred to as DP3 and so on. The term “maltodextrin” means a starch hydrolysis product having a DE of less than 20. The term “DE” (dextrose equivalent) means the reducing power (loss of electrons due to presence of carbonyl function) expressed as D-glucose on a dry basis. The term “dry basis” means the composition based on the absence of water. For instance, a product containing 25 wt. % of component A, 25 wt. % of component B and 50 wt. % of water would contain 50 wt. % of component A (or B) on a dry basis. The term “lactic acid” means 2-hydroxypropionic acid in either its free acid or salt form. The salt form of lactate is specifically referred to as lactate-salt, e.g. as either the calcium salt of lactic acid or calcium lactate. Alkali and earth alkali metal salts of lactic acid are preferred. Lactic acid contains a chiral carbon atom, and for that reason can exist as (R) and (S) enantiomer. The term “lactic acid” as used in this application includes the pure (R) and (S) isomers, and mixtures thereof including the racemic mixture. The term “enantiomeric purity” for an excess (S)-isomer means
- Enantiomeric purity=100% ×{((S)-isomer)/((R)-isomer+(S)-isomer)}
- The term “enantiomeric purity” for an excess (R)-isomer means
- Enantiomeric purity=100% ×{((R)-isomer)/((R)-isomer+(S)-isomer)}
- Many microorganisms, which are used for fermentation processes are unable to ferment starch, liquefied starch, maltodextrines or maltooligosaccharides since they lack either the enzymic machinery to liquefy starch or the enzymic machinery for saccharification or they lack both. The term “saccharification” means the acid- or enzymic-hydrolysis of starch or liquefied starch or maltodextrines or maltooligosaccharides that ultimately results in the production of D-glucose or maltose or small maltooligosaccharides or mixtures thereof. Fortifying cultures of these microorganisms with preparations of α-amylases or glucoamylases or pullulanase or mixtures thereof can conveniently solve this incompatibility problem. The term “α-amylase” means an enzyme belonging to the functional-class with the EC number 3.2.1.1 and the trivial name glycogenase, diastase, fungal α-amylase, or bacterial α-amylase, and the systematic name 1,4-α-D-glucan glucanohydrolase. α-Amylases partially depolymerize polysaccharides containing three or more 1,4-α-linked D-glucose units by endohydrolysis of 1,4-α-D-glucosidic linkages. The term “glucoamylase” means an enzyme belonging to the functional-class with the EC number 3.2.1.3 and the trivial name glucoamylase, γ-amylase, lysosomal α-glucosidase, acid maltase, exo-1,4-α-glucosidase, glucozyrne, AMG, or GAM, and the systematic name 1,4-α-D-glucan glucohydrolase. Glucoamylases hydrolyze terminal 1,4-linked α-D-glucose residues successively from the non-reducing ends of the chains with release of β-D-glucose, and they hydrolyze the α-1,6 linkages. The term “pullulanase” means an enzyme belonging to the functional-class with the EC number 3.2.1.41 and the trivial name limit-dextrinase, debranching enzyme, or amylopectin 6-glucanohydrolase, and the systematic name α-dextrin-6-glucanohydrolase or pullulan 6-glucanohydrolase. Pullulanases debranched starch by hydrolysing the α-1,6 linkages. The term “starch” means any purified or crude starch or liquefied starch, or any starch-or liquefied starch-containing material. Wheat, corn, rye, and potato starch are examples of starches that can usefully be applied in the present invention.
- Systems that combine the saccharification of starch or liquefied starch and fermentation of the saccharification products (glucose, maltose, small malto-oligosaccharides) are known as “simultaneous saccharification and fermentation” (SSF) processes. SSF systems hold considerable promise.
- Fermentation of starch or liquefied starch to lactic acid is known in the art, for example from EP 354828 A1, wherein a process for producing lactic acid is disclosed, which includes incubating Lactobacillus delbrueckii subsp lactis or Lactobacillus rhamnosus in fermentation broth containing liquefied wheat starch and a preparation of a glucoamylase to produce a lactate-containing fermentation broth. Hofvendahl et al in Appl. Biochem. Biotechnol., 52: 163-169 (1999) describe an SSF-system with Lactococcus lactis in fermentation broth-containing wheat starch. Linko et al in Enz. Microb. Technol., 19: 118-123 (1996) describe an SSF-system with Lactobacillus casei in fermentation broth-containing barley starch. U.S. Pat. No. 2,588,460 discloses a process to produce lactic acid which includes incubating Lactobacillus delbrueckii in fermentation broth-containing liquefied corn starch and a preparation of a glucoamylase to produce a lactate-containing fermentation broth. Mercier et al in J. Chem. Technol. Biotechnol., 55: 111-121 (1992) describe an SSF-system with Lactobacillus amylophilus in fermentation broth-containing liquefied corn starch. Cheng et al in J. Indust. Microbiol., 7: 27-34 (1991) and Zhang et al in Biotechnol. Letters, 13: 733-738 (1991) describe an SSF-system with Lactobacillus amylovorus in fermentation broth-containing liquefied corn starch. In U.S. Pat. No. 5,464,760 and WO 94/13826 processes to produce lactic acid are disclosed, which include incubating a mixed culture of (R)- and (S)-lactic acid-producing Lactobacillus species in fermentation broth-containing liquefied potato starch and a preparation of a glucoamylase to produce a lactate-containing fermentation broth. Tsai et al in Appl. Biochem. Biotechnol., 70/72: 417-428 (1998) describe an SSF-system with a Lactobacillus species in fermentation broth-containing potato starch. The term “fermentation broth” refers to both media in the form originally provided to microorganisms as a source of nutrients, growth factors and carbohydrates and media produced after some or all of the originally provided nutrients, growth factors, or carbohydrates have been consumed and fermentation products including lactic acid have been excreted into the media by the microorganisms.
- Although microorganisms such as Lactobacillus species, Lactococcus species, Streptococcus species, Enterococcus species, and Sporolactobacillus species are producers of lactic acid, certain properties make these organisms less suitable for the industrial manufacture of lactic acid, including the fact that they have a growth temperature in the range of 30-50° C., with an optimum at 30-37° C., which makes it more difficult to avoid infections in industrial scale fermentation systems, which compromise the enantiomeric purity of the lactic acid during the fermentation than when higher temperatures can be used.
- It is one of the objects of this invention to provide a method, which is devoid of this disadvantage of the known SSF processes.
- Furthermore the growth-temperature range of these microorganisms is not congruent with the application temperature range of glucoamylase and pullulanase, which is in the range of 50-70° C. and of α-amylase, which is in the range 80-105° C. A lactic fermentation with the microorganisms operated as SSF at a temperature which is optimal for these microorganism is sub-optimal for the activity of the enzyme. These reduced activities can be compensated by adding more glucoamylase, pullulanase or α-amylase or mixtures thereof, but this will add to the costs. Furthermore, these organisms require a fair amount of organic nitrogen in the fermentation medium, as well as growth promoting substances, so that the broth becomes more expensive and the lactic acid becomes more difficult to purify than when a simple fermentation medium can be used. On the part of these considerations it was found that more thermophilic nutritionally less demanding lactic acid-producing bacteria are more favorable.
- The invention therefore pertains to a method for the production of lactic acid or a salt thereof wherein starch is subjected to a process of simultaneous saccharification and fermentation, the method comprising saccharifying starch in a medium comprising at least a glucoamylase and simultaneously fermenting the starch using a microorganism, and optionally isolating lactic acid from the medium, characterized in that a moderately thermophilic lactic acid-producing microorganism is used.
- The use of moderately thermophilic Bacillus species for the manufacture of lactic acid from simple sugars such as glucose and sucrose is known in the art. The term “moderately thermophilic” means bacterial strains, which are capable of growing at temperatures between 30-65° C., with an optimum between 40-60° C., more preferably between 50-60° C. U.S. Pat. No. 5,002,881 and DE 4000942 disclose processes to produce lactic acid which include incubating strains of Bacillus coagulans at 48-54° C. in a simple fermentation medium containing either glucose or sucrose as carbohydrate to produce a lactate containing fermentation broth. DE 4000942, Olsen in Kemisk, 25: 125-130 (1944) and Payot et al in Enzyme Microb. Technol., 24: 191-199 (1999) describe a lactic fermentation at 50-60° C. without sterile conditions with Bacillus coagulans (i.e. Lactobacillus cereale) in fermentation medium with sucrose as carbohydrate to produce a lactate-containing broth. U.S. Pat. No. 6,022,537 discloses a moderately thermophilic amylolytic organism, Bacillus thermoamylovorans, which is useful for producing lactic acid.
- The use of moderately thermophilic lactic acid producing strains for the manufacture of lactic acid from starch (or liquefied starch) with SSF technology, however, has never been disclosed and has now been found to advantageously solve the temperature non-congruency that exists between the microorganism and the glucoamylase or pullulanase and to improve it for α-amylase. It is a further advantage of the present invention that enantiomerically pure lactic acid or a salt thereof can now easily be prepared. The term “enantiomerically pure” means that the enantiomeric purity is at least 95%, preferably at least 98%, and more preferably at least 99%. Although Bacillus coagulans and Bacillus thermoamylovorans are excellent lactate producers, they also have certain properties which at first sight would render these organisms less suitable candidates for the manufacture of enantiomerically pure lactic acid from starch or liquefied starch. Bacillus thermoamylovorans is heterolactic, which means that a fraction of the carbohydrate substrate is fermented to products other than lactic acid (ethanol, acetic acid, and formic acid), thereby lowering the product yield (mol lactic acid per mol carbohydrate) and rendering the product lactic acid more difficult to purify. Combet-Blanc et al in Appl. Environm. Microbiol., 65: 4582-4585 (1999); Appl. Environm. Microbiol., 61: 656-659 (1995); and Internat. J. System. Bacteriol., 45: 9-16 (1995) disclose that the lactate yield on glucose is typically in the order of 88-92% (mol lactic acid per mol glucose). Furthermore, it was also disclosed that the enantiomeric purity of the (S)-lactic acid was 98%. Bacillus coagulans is homolactic, which means that the carbohydrate is fermented to lactic acid only. Furthermore DE 4000942 discloses that the enantiomeric purity of the lactic acid is close to 100%. Bacillus coagulans on the other hand ferments starch or liquefied starch or maltodextrines or maltooligosaccharides poorly. Bacillus coagulans and Bacillus thermoamylovorans have a relatively high pH optimum (6.0-7.0) for lactic acid production, which is substantially higher in pH units than the preferred application (working) pH range of glucoamylase (3.5-5). The application pH range of glucoamylase is thus not congruent with that of the microorganism. A lactic fermentation with the moderately thermophilic Bacillus coagulans and Bacillus thermoamylovorans operated as SSF at a pH that is optimal for the microorganism, reduces the activity of the glucoamylase. This can be compensated by adding more glucoamylase, but this will add to the costs. It is therefore a further object of the invention to provide a method for using the SSF system suitable for use of moderately thermophilic lactic acid producing microorganisms such as Bacillus coagulans. This strain has a high rate of substrate conversion and high production yield. It is known, that at high free glucose concentrations glucoamylase can give a reversed reaction to produce α-1,4, α-1,6 and α-1,3 linkages from glucose producing sugars, such as maltose, isomaltose and nigerose, which are poorly or not fermentable by moderately thermophilic lactic acid bacteria (e.g. Reilly (1985): Enzymic degradation of starch in: Starch Conversion Technology (van Beynum and Roels ed), Marcel Dekker Inc, New York, pp 101-142). Application of SSF with moderately thermophilic lactic acid bacteria prevents the accumulation of free glucose in fermentation broth thereby preventing or reducing the rate of reversion reactions and thereby preventing the accumulation of non-fermentable sugars such as isomaltose and nigerose. This increases the lactate yield on starch or liquefied starch and renders the lactic acid present in the fermentation broth less difficult to purify.
- In a preferred embodiment the starch is saccharified, fermented, and optionally liquefied in a mixture of glucoamylase and at least one of pullulanase and α-amylase.
- The instant process results in that substantially less residual sugars are obtained compared with conventional fermentation processes, making direct isolation of lactic acid possible. The present invention thus provides in an advantage of an easy and inexpensive work-up procedure, not longer necessitating a complex extraction step to separate the lactic acid from residual sugars. An additional advantage of the instant process is the possibility of using crude starch, since the low residual sugar amounts not longer require the use of purified starch as starting product. Usually residual sugar contents less than 5 g/l, preferably less than 2 g/l are easily obtainable with the process of the invention.
- As indicated above, saccharification is performed by glucoamylase or a mixture of glucoamylase and α-amylase and/or pullulanase. Glucoamylase (EC 3.2.1.3, 1,4-α-D-glucan glucohydrolase) cleaves primarily α-1,4-glucosidic linkages at the non-reducing ends of both starch and the fragments left from α-amylase hydrolysis. Glucoamylase is an exohydrolase and attacks di-, oligo- and polysaccharides-containing glucose predominantly bound together by α-1,4-glucosidic linkages, though α-1,6-glucosidic linkages and α-1,3-glucosidic linkages are attacked at lower rates. This is of considerable industrial interest, as starch-hydrolysates after α-amylase treatment contain α-1,6-glucosidic linkages that must be cleaved if acceptable glucose yields are to be obtained. Since the activity of glucoamylase towards α-1,6-glucosidic linkages is low, some commercially available glucoamylase preparations contain pullulanase. Pullulanase is a so-called debranching enzyme, which cleaves the α-1,6-glucosidic linkages present in starch and liquefied starch. To saccharify liquefied starch, enzyme-containing glucoamylase as main component as well as combination preparations containing glucoamylase and pullulanase appeared suitable for the process according to the present invention. The application pH range for glucoamylase and pullulanase was found to be optimal between 3.5 and 5. The application temperature range was found optimal between 55-70° C. The effect of calcium lactate and pH on the activity and stability of the enzyme was found not to become progressively worse as a result of the accumulation of fermentation product.
- Even so, it is preferred to add the enzymes in at least two portions with regard to overall fermentation performance instead of a single addition at the beginning of the process. Commercially available glucoamylase/pullulanase preparations (ex Genencor and Novo Nordisk) were tested. All contained a considerable debranching activity. AMG™ E (ex Novo Nordisk), a glucoamylase with a high debranching activity, Dextrozyme™ E (containing glucoamylase and pullulanase) (ex NOVO Nordisk), and Optimax™ 7525 HP (containing glucoamylase and pullulanase) (ex Genencor) were also tested and again no large difference was observed between these preparations. Dextrozyme™ E performed slightly less than AMG™ E and Optimax™ 7525 HP regarding overall fermentation performance. AMG™ E and Optimax™ 7525 HP performed almost identical and both enzyme preparations were studied in detail (see Experimental).
- The fermentation is performed by a moderately thermophilic lactic acid producing microorganism such as microorganisms derived from a strain of Bacillus coagulans, Bacillus thermoamylovorans, Bacillus smithii, Geobacillus stearothermophilus, or from mixtures thereof. These microorganisms are capable of growing at temperatures between 30-65° C. Thus these microorganism are better adjusted to work in the optimal working temperatures of the enzymes and the process according to the invention is usually conducted at a temperature between 30-70° C. The method of the invention is usually performed at pH 3-8.5, preferably at pH 5-6, more preferably at pH 5.35-5.80, most preferably at pH 5.50-5.60.
- It is an advantage to adapt the thermophilic lactic acid-producing microorganism to the pH range as used in the process. The pH strongly influences the activity. The enzymes become progressively more active at low pH values. However, the common pH ranges in which moderately thermophilic lactic acid-producing microorganism perform optimal is between 6.0 and 7. Therefore, it is preferred to use moderately thermophilic lactic acid-producing microorganism, which has been adapted to have its maximum performance at low pH (between 5 and 6, preferably between 5.35-5.80, most preferably between 5.35-5.80). The technique of adapting the microorganism is known in the art. Adaptation or acclimation of moderately thermophilic lactic acid-producing bacteria to improve the performance at pH 5.35-5.8 was accomplished by carrying out 40-50 serial transfers in fermentation medium at pH 5.6.
- The simultaneous saccharification and fermentation may be performed on a starch slurry or on any other starch-containing composition. Said starch may be liquefied or not. If a non-liquefied starch slurry or any other starch containing composition is used, the saccharification and fermentation may be combined with liquefaction and also an α-amylase may be present in the fermentation medium.
- A full saccharification step may last up to 72 hours. However, it is possible to do a pre-saccharification of typically 40-90 minutes and then complete saccharification during fermentation. Said pre-saccharification step may be conducted at a temperature above 50° C., just prior to the fermentation. The most widely used process is a simultaneous saccharification and fermentation (SSF) process where there is no holding stage for the saccharification, meaning that fermenting organism and enzyme(s) is (are) added together. In the process according to the invention, the moderately thermophilic lactic acid producing microorganism and enzyme(s) may also be added simultaneously. It goes without saying that the process according to the invention may also be performed by a pre-saccharification followed by a simultaneous saccharification and fermentation wherein an additional portion of the enzymes is added with the addition of the moderately thermophilic lactic acid-producing microorganism.
- A starch slurry or slurry of a suitable starch-containing material or liquefied starch is fed into a fermenter. The microbial inoculum and nutrients are also fed into the fermenter. During the fermentation a suitable base such as calcium hydroxide, sodium hydroxide, potassium hydroxide, magnesium hydroxide, magnesium oxide, ammonia, ammonium hydroxide or a suitable carbonate such as calcium carbonate, sodium carbonate, sodium hydrogencarbonate, potassium carbonate, potassium hydrogencarbonate, magnesium carbonate, ammonium carbonate may be added for pH control.
- When applied, in the liquefaction step of the invention, gelatinized starch or starch containing material is broken down (hydrolyzed) to maltodextrines with an average DE between 10 and 30. The term “gelatinization” means the process that transforms starch granules into starch paste. The hydrolysis may be carried out by acid treatment or enzymatically by α-amylase treatment. The α-amylase derived from a microorganism or a plant. Preferred α-amylases are of fungal or bacterial origin. A definition of α-amylase is given above. The enzymatic liquefaction process may be carried out at a pH between 5 and 6, preferably between 5.35 and 5.80, and more preferably between 5.50 and 5.60. Thus, enzymatic liquefaction may advantageously be combined with either the pre-saccharification or the simultaneous saccharification and fermentation or with both. Acid hydrolysis, although its use is not wide spread, may also be used. The raw material may be milled (whole) cereals or rasped, shredded roots (potato, tapioca), tubers, whole grains, corns, cobs, wheat, barley, rye, milo, sugar-containing raw materials, such as molasses, fruit materials, sugar, cane or sugar beet, potatoes, cellulose-containing materials, such as wood or plant residues.
- However, a side stream from starch processing such as co-called B-starch may also be used. Liquefaction is known in the art and needs no further elucidation here. As indicated-above, the liquefaction may also take place in combination with the saccharification and fermentation.
- In a preferred embodiment of the invention the liquefaction step comprises the following steps:
- 1) the hot slurry is heated to between 60-95° C., preferably 80-85° C., and at least an α-amylase is added;
- 2) the slurry is jet-cooked at a temperature between 95-140° C., preferably 105-125° C. to complete gelanitization of the slurry;
- 3) the slurry is cooled to 60-95° C. and more α-amylase is added to finalize. hydrolysis.
- The liquefaction process may be carried out at pH 5-6, in particular at a pH between 5.35 and 5.80, most preferably at pH 5.50-5.60.
- After combined saccharification and fermentation the formed lactic acid is optionally isolated from the fermentation medium and purified when necessary. Conventional purification/isolation methods for lactic acid are distillation, extraction, electrodialysis, adsorption, ion-exchange, crystallization and the like, and combinations of the above-mentioned purification/isolation methods. Distillation is the most commonly used technique. However, as explained above, with the process according to the invention the formation of non-fermentable sugars is reduced. Therefore, isolation or purification steps may be less complicated and sometimes even redundant. Further details on how to carry out distillation, and other techniques for recovering of lactic acid are well known to the skilled person. The invention is further illustrated by the following experiments, which are included without restricting the invention thereto.
- The culture Bacillus coagulans that was adapted to pH 5.65 was cultivated in a 3-liter glass jacketed stirred reactor equipped with temperature and pH control (Applikon, Schiedam, The Netherlands). The culture was routinely maintained, by transferring every 24 hours 180-200 ml of an actively fermenting culture to a fermenter containing a freshly prepared batch of maltodextrine-medium (see Table 1). Fermentations were performed with pure maltodextrines as well as liquefied starch from the Cargill Refinery in Blair (Nebraska, USA) and glucose syrup also from the Cargill Refinery in Blair (Nebraska, USA)(see Table 1).
-
TABLE 1 Composition of fermentation media for SSF and glucose fermentations Liquefied Maltodextrine Glucose Component starch medium medium medium Glucose syrup DE 98, 51.7% dry solids* — — 800 g Maltodextrine DE 11-14, 95% dry solids — 382 g — Liquefied starch DE 9-11, 35% dry 1.1 l — — solids* Diammonium phosphate 7 g 7 g 7.0 g Chalk (Whiting) 26.7 g 26.7 g 26.7 g Yeast extract (65% DS) 3.4 g 3.4 g 3.4 g Demineralised water (in l) 0.5 l 1.3 l 1.0 l AMG E ™ (Novozymes) 0.65-0.7 ml 0.65-0.7 ml — first portion at start of fermentation AMG E ™ (Novozymes) 0.3-0.35 ml 0.3-0.35 ml — second portion after 24 hours fermentation *ex Cargill, Blair, Nebraska, USA - The temperature of the fermenters was controlled at 54-56° C. by means of a circulating water bath. The pH set point was a compromise between the optimum pH of the enzyme and the optimum for Bacillus coagulans that was adapted to pH 5.65. The fermentation was started at pH 6.0 and as a result of the formation of lactic acid allowed to drop. Upon reaching pH 5.55-5.75 the pH was controlled by the automatic addition of calcium hydroxide (250 g/l). After 24 hours fermentation the culture received a second portion of AMG E™ (Novozymes). The fermentation was allowed to proceed until the demand for calcium hydroxide ceased. This was the case after 30-40 hours incubation.
- The benchmark for the SSF fermentation was set by the fermentation with glucose syrup (DE 98) as substrate. The SSF study was started with a maltodextrine preparation from Roquette Freres (Glucidex™ 12, DE 11-14) and successfully finished. Two glucoamylase preparations were extensively tested: AMG E™ from Novozymes (glucoamylase with high debranching activity) and Optimax™ 7525 HP from Genencor (glucoamylase/pullulanase). A typical SSF fermentation on pure maltodextrines was free of residual sugars within 2 days. The main residual sugars present were glucose and isomaltose, however, at a consistently lower concentration than in comparable cultures that received DE 98 glucose syrup as substrate. Maltose concentrations were low (<50 mg/l) in contrast to comparable DE 98 cultures running at pH 6.4-6.6. A considerable amount of maltose was introduced in the fermentation with the addition of Glucidex 12. The fact that maltose could be fermented at low pH was a significant finding. The fermentation yield (mol (S)-lactate produced per mol glucose consumed) was slightly higher than 100%. Organic acids in sugar free SSF broth were analyzed and levels were comparable with Bacillus coagulans fermentations at pH 6.4-6.6. Below pH 5.55 the SSF fermentation was relatively slow. At pH 5.90, a 50% increase in total residual sugar was observed compared to cultures running between pH 5.55-5.75. Similar results were obtained using the crude liquefied starch. In the final stage, successful SSF experiments were performed with crude liquefied starch hydrolysates. There was no difference observed between the SSF fermentation on purified maltodextrines and the liquefied starch from the Cargill Refinery regarding fermentation time. Both SSF fermentations finished in 30-40 hours. Cultures containing crude liquefied starch or maltodextrin as substrate typically contained 180-200 g/l of (S)-lactic acid. The enantiomeric purity of the lactic acid was better than 99.5%
- SSF Experiments using Various Moderately Thermophilic Microorganisms
- SSF experiments were conducted with Bacillus coagulans, Bacillus thermoamylovorans, Bacillus smithii, Geobacillus stearothennophilus, and a mixture of all four. Hereto, the cultures were grown and used in the combined saccharification and fermentation of liquefied starch, using the same procedure and conditions as in the above-described SSF experiments. All microorganisms used (including the mixed culture), were able to produce lactic acid with high optical purity. The results are compiled in Table 2.
-
TABLE 2 SSF with various moderately thermophilic microorganisms Optical purity Microorganism Lactic acid yield (g/l) (% S-lactate) Bacillus coagulans 35.5* 99.8 Bacillus smithii 18.3* 99.4 Bacillus thermoamylovorans 14.4** 99.6 Geobacillus stearothermophilus 8.7** 99.3 Mixed culture of Bacillus 13.9** 99.7 coagulans, Bacillus smithii, Bacillus thermoamylovorans and Geobacillus stearotrhermophilus *4.5% starch input **1.6% starch input
Claims (13)
1. A method of producing lactic acid or a salt thereof, wherein starch is subjected to a process of simultaneous saccharification and fermentation, the method comprising:
saccharifying starch in a medium comprising at least a glucoamylase;
simultaneously fermenting the starch by using a moderately thermophilic lactic acid-producing microorganism; and
optionally isolating lactic acid from the medium;
wherein:
the moderately thermophilic lactic acid-producing microorganism is derived from a strain of Bacillus coagulans, Bacillus smithii, or from a mixture thereof.
2. The method according to claim 1 , wherein the starch is saccharified, fermented, and optionally liquefied, in a mixture of glucoamylase and at least one of pullulanase and α-amylase.
3. The method according to claim 1 , wherein the lactic acid or a salt thereof has an enantiomeric purity of at least 95%.
4. The method according to claim 1 , wherein the process is performed at pH 3-8.5.
5. The method according to claim 4 , wherein the process is performed at pH 5-6.
6. The method according to claim 5 , wherein the process is performed at pH 5.35-5.80.
7. The method according to claim 6 , wherein the process is performed at pH 5.50-5.60.
8. The method according to claim 1 , wherein the microorganism is adapted to a pH range at which the process is performed.
9. The method according to claim 1 , wherein the microorganism is adapted to a pH range of 5-5.80.
10. The method according to claim 1 , wherein the process is performed at 30-70° C.
11. The method according to claim 10 , wherein the process is performed at 40-60° C.
12. The method according to claim 11 , wherein the process is performed at 50-60° C.
13. The method according to claim 2 , wherein the glucoamylase or the mixture of glucoamylase and at least one of pullulanase and α-amylase is added in at least two portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/155,180 US20080261285A1 (en) | 2002-05-14 | 2008-05-30 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076954 | 2002-05-14 | ||
| EP02076954.3 | 2002-05-14 | ||
| EP02077648 | 2002-06-10 | ||
| EP02077648.0 | 2002-06-10 | ||
| PCT/EP2003/050159 WO2003095659A1 (en) | 2002-05-14 | 2003-05-13 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
| US10/514,161 US8119376B2 (en) | 2002-05-14 | 2003-05-13 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
| US12/155,180 US20080261285A1 (en) | 2002-05-14 | 2008-05-30 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/514,161 Division US8119376B2 (en) | 2002-05-14 | 2003-05-13 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
| PCT/EP2003/050159 Division WO2003095659A1 (en) | 2002-05-14 | 2003-05-13 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20080261285A1 true US20080261285A1 (en) | 2008-10-23 |
Family
ID=29421898
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/514,161 Expired - Lifetime US8119376B2 (en) | 2002-05-14 | 2003-05-13 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
| US12/155,180 Abandoned US20080261285A1 (en) | 2002-05-14 | 2008-05-30 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
| US12/155,177 Abandoned US20080261284A1 (en) | 2002-05-14 | 2008-05-30 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/514,161 Expired - Lifetime US8119376B2 (en) | 2002-05-14 | 2003-05-13 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/155,177 Abandoned US20080261284A1 (en) | 2002-05-14 | 2008-05-30 | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8119376B2 (en) |
| EP (1) | EP1504109B2 (en) |
| JP (1) | JP4405914B2 (en) |
| CN (1) | CN1316031C (en) |
| AT (1) | ATE365221T1 (en) |
| AU (1) | AU2003240845A1 (en) |
| BR (1) | BRPI0309981B1 (en) |
| DE (1) | DE60314513T3 (en) |
| WO (1) | WO2003095659A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011098843A2 (en) | 2010-02-10 | 2011-08-18 | Sveučilište u Zagrebu | Lactic acid production from starch-based materials by amylolytic lactic acid bacteria |
| CN111808775A (en) * | 2020-07-24 | 2020-10-23 | 南京高新工大生物技术研究院有限公司 | A thermostable Bacillus amylophaga and its application |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1294728B1 (en) | 1997-09-12 | 1999-04-12 | Biopolo S C A R L | YEAST STRAWS FOR THE REPRODUCTION OF LACTIC ACID |
| EP2799553B1 (en) | 2004-03-31 | 2020-07-29 | Cargill, Incorporated | Process for fermenting sugars containing oligomeric saccharides |
| DE102004026152A1 (en) * | 2004-05-28 | 2005-12-15 | Basf Ag | Fermentative production of fine chemicals |
| CA2623751A1 (en) | 2005-09-22 | 2007-04-05 | Tate & Lyle Ingredients Americas, Inc. | Improved strains for the production of organic acids |
| JP2007153951A (en) * | 2005-12-01 | 2007-06-21 | Ccy:Kk | Method for producing liquefied starch and method for producing lactic acid |
| WO2007140277A1 (en) * | 2006-05-24 | 2007-12-06 | Vitality Concepts Corporation | Method for embedding and targeted release of micronutrients in activated dietary fibers |
| FI20065762A0 (en) * | 2006-11-30 | 2006-11-30 | Oulun Yliopisto | Procedure for controlling growth in cell culture |
| CN101003819B (en) * | 2007-01-17 | 2011-11-02 | 哈尔滨工业大学 | Zymolysis method for producing lactic acid by bacillus subtilis to saccharify garbage from restaurant and cookroom |
| TW200904340A (en) | 2007-05-11 | 2009-02-01 | Mannatech Inc | Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same |
| JP2010017116A (en) * | 2008-07-09 | 2010-01-28 | National Institute Of Advanced Industrial & Technology | Method of manufacturing organic acid using malted rice |
| IT1393393B1 (en) * | 2009-03-23 | 2012-04-20 | Cusinato Giovanni S R L | METHOD AND PLANT FOR THE TRANSFORMATION OF PRODUCTS CONTAINING AMID, IN PARTICULAR PASTA AND WHEAT FOOD BREAD, IN A HIGH-NUTRITIONAL VALUE SYRUP, CONTAINING ENZYMES, ORGANIC ACIDS, SUGARS AND PROTEINS, AMINO ACIDS AND VITAMINS |
| EP2311968A1 (en) | 2009-10-14 | 2011-04-20 | PURAC Biochem BV | Fermentation process at reduced pressure |
| CN101805759B (en) * | 2010-04-21 | 2012-07-04 | 山东大学 | Method for producing L-lactic acid by taking cassava powder as material |
| EP2601300A1 (en) | 2010-08-06 | 2013-06-12 | Danisco US Inc. | Production of isoprene under neutral ph conditions |
| CN103068997A (en) | 2010-08-06 | 2013-04-24 | 丹尼斯科美国公司 | Neutral ph saccharification and fermentation |
| WO2012149288A1 (en) | 2011-04-29 | 2012-11-01 | Danisco Us Inc. | Single ph process for starch liquefaction and saccharification for high-density glucose syrups |
| HK1198837A1 (en) | 2011-08-05 | 2015-06-12 | Danisco Us Inc. | Production of isoprenoids under neutral ph conditions |
| US9567574B2 (en) * | 2011-09-09 | 2017-02-14 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
| EP2604696A1 (en) | 2011-12-16 | 2013-06-19 | PURAC Biochem BV | Process for the fermentative production of lactic acid from a plant extract in the presence of a caustic magnesium salt |
| CN103789362B (en) * | 2014-02-25 | 2015-10-28 | 河南金丹乳酸科技股份有限公司 | A kind of premashing and simultaneous saccharification and fermentation produce the method for lactic acid |
| PL3174988T3 (en) | 2014-07-28 | 2023-01-02 | Purac Biochem Bv | Method for the preparation of lactic acid |
| KR102559034B1 (en) | 2015-06-29 | 2023-07-24 | 피티티 글로벌 케미칼 피씨엘 | Method for producing lactic acid or its salt from fermentation using heat-resistant Bacillus bacteria |
| CA3019265C (en) * | 2016-04-12 | 2022-03-08 | Purac Biochem Bv | Magnesium lactate fermentation process |
| CN106222107B (en) * | 2016-08-05 | 2019-07-26 | 福建省农业科学院畜牧兽医研究所 | An extremely thermophilic bacterium from pig farm waste |
| CN109380684A (en) * | 2017-08-08 | 2019-02-26 | 贵州美人芋农业发展有限公司 | A kind of banana dasheen antibacterial starch and preparation method thereof |
| CN109769937A (en) * | 2017-11-15 | 2019-05-21 | 内蒙古伊利实业集团股份有限公司 | A kind of malto-oligosaccharide Yoghourt and preparation method thereof |
| CN110358798B (en) * | 2019-08-21 | 2020-09-11 | 浙江省桐庐汇丰生物科技有限公司 | Method for producing validamycin by fermentation |
| CN115315520A (en) * | 2020-03-24 | 2022-11-08 | 三W有限公司 | Production of lactic acid from organic waste using a composition of BACILLUS COAGULANS (BACILLUS COAGULANS) spores |
| CN112501219B (en) * | 2020-12-30 | 2022-12-13 | 天津科技大学 | A method for producing lactic acid monomer by fermenting sucrose as raw material |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2474046A (en) * | 1945-10-19 | 1949-06-21 | Rhinelander Paper Company | Process of producing lactic acid |
| US5079164A (en) * | 1989-03-10 | 1992-01-07 | Jungbunzlauer Aktiengesellschaft | Microorganism of the species bacillus ciaguans |
| US5464760A (en) * | 1990-04-04 | 1995-11-07 | University Of Chicago | Fermentation and recovery process for lactic acid production |
| US6022537A (en) * | 1994-01-18 | 2000-02-08 | Institut Francais De Recherche Scientifique Pour Le Developpement En Cooperation (Orstom) | Bacterial strains of the genus Bacillus, closely phenotypically related to the genus Lactobacillus, culture method and use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8801516A (en) | 1988-06-14 | 1990-01-02 | Suiker Unie | PROCESS FOR THE FERMENTATIVE PREPARATION OF ORGANIC ACIDS. |
| FR2635334B1 (en) | 1988-08-10 | 1990-11-09 | Rhone Poulenc Chimie | PROCESS FOR PRODUCING LACTIC ACID BY FERMENTATION |
| EE04529B1 (en) * | 2001-03-16 | 2005-08-15 | Tartu �likool | Thermophilic microorganism strain Bacillus coagulans SIM-7 DSM 14043 and method for the production of L (+) - lactate from fermentable sugars and mixtures thereof by said microorganism strain |
-
2003
- 2003-05-13 BR BRPI0309981-4A patent/BRPI0309981B1/en active IP Right Grant
- 2003-05-13 EP EP03730209A patent/EP1504109B2/en not_active Expired - Lifetime
- 2003-05-13 JP JP2004503649A patent/JP4405914B2/en not_active Expired - Lifetime
- 2003-05-13 CN CNB038148862A patent/CN1316031C/en not_active Expired - Lifetime
- 2003-05-13 AT AT03730209T patent/ATE365221T1/en not_active IP Right Cessation
- 2003-05-13 DE DE60314513T patent/DE60314513T3/en not_active Expired - Lifetime
- 2003-05-13 US US10/514,161 patent/US8119376B2/en not_active Expired - Lifetime
- 2003-05-13 WO PCT/EP2003/050159 patent/WO2003095659A1/en not_active Ceased
- 2003-05-13 AU AU2003240845A patent/AU2003240845A1/en not_active Abandoned
-
2008
- 2008-05-30 US US12/155,180 patent/US20080261285A1/en not_active Abandoned
- 2008-05-30 US US12/155,177 patent/US20080261284A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2474046A (en) * | 1945-10-19 | 1949-06-21 | Rhinelander Paper Company | Process of producing lactic acid |
| US5079164A (en) * | 1989-03-10 | 1992-01-07 | Jungbunzlauer Aktiengesellschaft | Microorganism of the species bacillus ciaguans |
| US5464760A (en) * | 1990-04-04 | 1995-11-07 | University Of Chicago | Fermentation and recovery process for lactic acid production |
| US6022537A (en) * | 1994-01-18 | 2000-02-08 | Institut Francais De Recherche Scientifique Pour Le Developpement En Cooperation (Orstom) | Bacterial strains of the genus Bacillus, closely phenotypically related to the genus Lactobacillus, culture method and use |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011098843A2 (en) | 2010-02-10 | 2011-08-18 | Sveučilište u Zagrebu | Lactic acid production from starch-based materials by amylolytic lactic acid bacteria |
| CN111808775A (en) * | 2020-07-24 | 2020-10-23 | 南京高新工大生物技术研究院有限公司 | A thermostable Bacillus amylophaga and its application |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1504109B1 (en) | 2007-06-20 |
| EP1504109A1 (en) | 2005-02-09 |
| BR0309981A (en) | 2005-03-22 |
| US8119376B2 (en) | 2012-02-21 |
| DE60314513D1 (en) | 2007-08-02 |
| EP1504109B2 (en) | 2011-05-18 |
| BRPI0309981B1 (en) | 2019-10-01 |
| AU2003240845A1 (en) | 2003-11-11 |
| WO2003095659A1 (en) | 2003-11-20 |
| DE60314513T2 (en) | 2008-03-13 |
| ATE365221T1 (en) | 2007-07-15 |
| JP2005525120A (en) | 2005-08-25 |
| CN1316031C (en) | 2007-05-16 |
| DE60314513T3 (en) | 2012-01-26 |
| US20050176120A1 (en) | 2005-08-11 |
| JP4405914B2 (en) | 2010-01-27 |
| CN1662653A (en) | 2005-08-31 |
| US20080261284A1 (en) | 2008-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8119376B2 (en) | Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch | |
| Aiyer | Amylases and their applications | |
| EP1581617B1 (en) | Methods for producing end-products from carbon substrates | |
| Saha | Production of mannitol from inulin by simultaneous enzymatic saccharification and fermentation with Lactobacillus intermedius NRRL B-3693 | |
| US10655151B2 (en) | Process for fermenting sugars containing oligomeric saccharides | |
| US20150152457A1 (en) | Direct starch to fermentable sugar | |
| JPH0276592A (en) | Production of lactic acid | |
| US8227220B2 (en) | Process for the preparation of ethanol from starch | |
| WO2011098843A2 (en) | Lactic acid production from starch-based materials by amylolytic lactic acid bacteria | |
| CN102260726B (en) | Pretreatment method of starchiness raw material | |
| Kumar et al. | Diversity and biotechnological applications of microbial glucoamylases | |
| JP4221558B2 (en) | Method for producing lactic acid | |
| EP3835426B1 (en) | Process for the preparation of a fermentable sugar composition and the fermentation thereof | |
| WO2026017908A2 (en) | Means and methods for hydrolyzing carbohydrates present in raw materials containing carbohydrates | |
| WO2018226569A1 (en) | Use of betaine to stabilize and/or increase the activity of enzymes in stressful environments | |
| US20230052467A1 (en) | Methods of producing lactic acid from unmodified starch | |
| Wong | Production of L-lactic acid from starch by recombinant Bacillus subtilis 1A304 (Ф105MU331) | |
| HRP20100074A2 (en) | Lactic acid production from starch-containing raw materials by amylolytic lactic acid bacteria | |
| Shamtsyan et al. | Continuous production of lactic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |